Farzin Haque
Stock Analyst at Jefferies
(2.85)
# 1,622
Out of 5,131 analysts
4
Total ratings
50%
Success rate
87.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Farzin Haque
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Initiates: Buy | $9 | $4.11 | +118.98% | 1 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $6.46 | +54.80% | 1 | Sep 30, 2025 | |
| PYXS Pyxis Oncology | Assumes: Buy | $10 | $2.06 | +385.44% | 1 | May 7, 2024 | |
| VERA Vera Therapeutics | Upgrades: Buy | $18 → $26 | $46.46 | -44.04% | 1 | Nov 10, 2023 |
Relmada Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $9
Current: $4.11
Upside: +118.98%
Nuvation Bio
Sep 30, 2025
Initiates: Buy
Price Target: $10
Current: $6.46
Upside: +54.80%
Pyxis Oncology
May 7, 2024
Assumes: Buy
Price Target: $10
Current: $2.06
Upside: +385.44%
Vera Therapeutics
Nov 10, 2023
Upgrades: Buy
Price Target: $18 → $26
Current: $46.46
Upside: -44.04%